
World's first synthetic, non-biologic flu vaccine that can be given as a pill has been developed, reveals a new study.
The tablet does not need refrigeration, which makes it easier to transport and suitable for developing countries with warm climates.
Advertisement
‘Flu pills do not need refrigeration and can be easily available for all people.’
Tweet it Now
Scientists at the University of Cardiff produced the pill by creating synthetic "mirror image" versions of protein molecules.
Lead scientist Professor Andrew Sewell said: "There are many benefits of oral vaccines. Not only would they be great news for people who have a fear of needles, but they can also be much easier to store and transport, making them far more suitable for use in remote locations where current vaccine delivery systems can be problematic."
Scientists claim that this new pill could herald a "revolution in vaccine delivery."
The research was published in the Journal of Clinical Investigation, and has been confined to a proof-of-concept laboratory study.
However, it might take many more years before a non-biological pill vaccine is tested on patients, revealed scientists.
Source: Medindia
Advertisement
Scientists claim that this new pill could herald a "revolution in vaccine delivery."
The research was published in the Journal of Clinical Investigation, and has been confined to a proof-of-concept laboratory study.
However, it might take many more years before a non-biological pill vaccine is tested on patients, revealed scientists.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The reverse vaccine uses the liver's natural "non-target" signals to prevent autoimmune responses against naturally decaying cells.

The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.

The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.

Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.

Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.